IP Library Granted Patent US 11,707,557
Granted Patent B2
US 11,707,557 · App. 17/591,806 · Granted Jul 25, 2023

Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof

Inventor: John K. Jackson (West Vancouver, CA)
Assignee: Cook Medical Technologies LLC
A61L31/16A61K31/337A61K31/353A61K31/436A61K31/58A61L27/34A61L27/44A61L27/54A61L29/08A61L29/085A61L29/16A61L31/08A61L31/10A61M25/09A61M25/10A61L2300/416A61L2300/426A61L2300/602A61L2300/606A61L2300/61A61L2420/06A61M2025/105H05K999/99
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,707,557
App. No.
17/591,806
Granted
Jul 25, 2023
Kind
B2
Abstract

Various aspects of the present disclosure provide compositions including a water-insoluble therapeutic agent and a gallate-containing compound. Other aspects provide methods of using such compositions.

Claims (20)

1. A composition for the treatment of a medical condition, comprising:

a topical drug preparation comprising a gallate containing compound and a water-insoluble drug, where the gallate containing compound is present in an amount by weight equal to or greater than the amount by weight of the water-insoluble drug.

2. The composition of claim 1 , where the gallate containing compound is selected from the group consisting of epi gallo catechin gallate and tannic acid.

3. The composition of claim 2 , where the topical preparation comprises a cream, paste, gel, or ointment.

4. The composition of claim 1 , where the drug is selected from paclitaxel, docetaxel, amphotericin, curcumin, retinoic acid, finasteride, and lidocaine.

5. The composition of claim 1 , where the drug is an anesthetic.

6. The composition of claim 5 , where the preparation is nonaqueous.

7. The composition of claim 5 , where the topical preparation comprises a cream, paste, gel, or ointment.

8. The composition of claim 5 , where the drug is lidocaine.

9. The composition of claim 5 , where the topical drug preparation comprises a eutectic solution.

10. The composition of claim 9 , where the solution comprises menthol.

11. The composition of claim 1 , where the drug has a molecular weight greater than 500 Daltons.

12. The composition of claim 1 , further comprising a solubilizing excipient.

13. The composition of claim 1 , where the topical drug preparation comprises a eutectic solution.

14. The composition of claim 12 , where the solution comprises menthol.

15. The composition of claim 1 , where the weight ratio of gallate containing compound:water-insoluble drug is in the range of 200:1 to 1:1, 200:1 to 5:1, 200:1 to 10:1, 200:1 to 30:1, 200:1 to 50:1, 100:1 to 1:1, 100:1 to 5:1, 100:1 to 10:1, 100:1 to 30:1, 100:1 to 50:1, 50:1 to 1:1, 50:1 to 5:1, 10:1 to 1:1, or 10:1 to 5:1.

16. The composition of claim 1 , where the topical preparation comprises a cream, paste, gel, or ointment.

17. The composition of claim 1 , where the topical preparation comprises a preblended solid or semi solid matrix of the gallate containing compound and the drug.

18. The composition of claim 1 , where the gallate containing compound and the drug are predispersed in one of a membrane, a hydrogel, an electrospun film, or a skin dressing.

19. The composition of claim 1 , where the preparation is nonaqueous.

Assignments (2)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2023
From: JACKSON, JOHN K
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 063851/0053 →